Patient-reported outcomes: central to the management of COVID-19
- 22 August 2020
- journal article
- letter
- Published by Elsevier BV in The Lancet
- Vol. 396 (10250), 531
- https://doi.org/10.1016/S0140-6736(20)31724-4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Planning for a COVID-19 Vaccination ProgramJAMA, 2020
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trialThe Lancet, 2020
- Virtually Perfect? Telemedicine for Covid-19The New England Journal of Medicine, 2020
- Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer TreatmentJAMA, 2017
- Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)JAMA Oncology, 2015